Susan E. Waltz

Veterans Health Administration — United States

Medicine · Health Sciences

41h-index4.5kcitations239works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(66), Axon Guidance and Neuronal Signaling(44), Phagocytosis and Immune Regulation(30), Cancer Mechanisms and Therapy(28), Apelin-related biomedical research(26)

Publications239 total

Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro
Cancers·2025Open Access
Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms
Oncotarget·2025· 8 citedOpen Access
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Metastatic Behavior
Preprints.org·2025Open Access
RON Receptor Signaling and the Tumor Microenvironment
Genes·2025Open Access
Reversing the Rivers: A Memoir of History, Hope, and Human Rights by William F. Schulz (review)
Human Rights Quarterly·2025
Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma
Cancer Letters·2024· 6 citedOpen Access
Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes
Frontiers in Oncology·2024Open Access
The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism
Genes·2024· 3 citedOpen Access
Summary and Roadmap of Breast Cancer Research in the Veterans Affairs
Military Medicine·2024Open Access
Human Rights and Reform
2023· 5 cited
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness
Science Advances·2023· 14 citedOpen Access
RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence
Oncogene·2023· 13 citedOpen Access
Abstract 377: RON receptor tyrosine kinase in head and neck cancer: a potential target for overcoming resistance to anti-EGFR therapy
Cancer Research·2023
Abstract 1243: RON receptor signaling enhances prostate cancer metastasis in Hi-Myc mice
Cancer Research·2023
Supplementary Table 1 from Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
2023Open Access
Supplemental Figure 1 from Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression
2023Open Access
Supplementary Figure 3 from Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
2023Open Access
Supplementary Figure 1 from Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
2023Open Access
Supplementary Table 1 from Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
2023Open Access
Supplementary Figure 1 from Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Sandra J. Friezner Degen(8), Purnima K. Wagh(6), Belinda E. Peace(6), Kenya Toney‐Earley(6), Jerilyn K. Gray(6), Megan N. Thobe(5), Mike A. Leonis(4), Peterson Pathrose(4), Devikala Gurusamy(4), Alex B. Lentsch(3), William D. Stuart(3), Rebecca J. McClaine(3), Glendon M. Zinser(3), Shao‐Chun Wang(3), Rebecca S. Muraoka(3), Nancy M. Benight(3), Juozas Vasiliauskas(3), Sasha J. Ruiz-Torres(3), Susan A. McDowell(3), Ryan M. Thomas(2)